Tofersen slowed the progress of the debilitating condition in some patients with no other options. The Daily Mail
See also:
- Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS (abstract) New England Journal of Medicine
- Promising MND drug helps slow disease progression and benefits patients physically The University of Sheffield
- 'Truly remarkable' drug helps motor neurone disease BBC News
No comments:
Post a Comment